盐酸普拉克索缓释片的临床应用进展

被引：12

作者：

刘玉丽

机构：

[1] 内蒙古医科大学附属人民医院药剂科

来源：

国际药学研究杂志 | 2014年 / 41卷 / 01期

关键词：

帕金森病; 普拉克索; 缓释; 临床应用;

D O I：

10.13220/j.cnki.jipr.2014.01.015

中图分类号：

R971.5 [];

学科分类号：

1007 ;

摘要：

药物治疗仍是缓解帕金森病的主要方法。大量临床试验结果证明了盐酸普拉克索片(pramipexole dihydrochloride,Mirapex IR)治疗帕金森病的安全性及有效性;与Mirapex IR相比,盐酸普拉克索缓释片(Mirapex ER)能够维持血药浓度相对恒定,作用更连续持久,而且在某种程度上减少了不良反应的发生,增加了患者和护理人员的便利,明显提高患者的依从性,为帕金森病的治疗提供了新选择。本文综述了Mirapex ER的临床应用进展。

引用

页码：98 / 101

页数：4

共 10 条

[1] 多巴胺受体激动剂的药理研究进展 [J].

江丽欢 .

中国实用医药, 2011, 6 (02) :232-234

[2]

普拉克索添加治疗帕金森病的临床研究[J]. 葛许华,于春雨,孔德莲,秦敬翠,周联生.浙江临床医学. 2011 (10)

[3]

Efficacy and Safety of a Once-daily Extended-release Formulation of Pramipexole Switched from an Immediate-release Formulation in Patients with Advanced Parkinson's Disease: Results from an Open-label Study[J] . M. Takanashi,Y. Shimo,T. Hatano,G. Oyama,N. Hattori.Drug Res (Stuttg) . 2013

[4]

Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease[J] . A. H. V. Schapira,P. Barone,R. A. Hauser,Y. Mizuno,O. Rascol,M. Busse,C. Debieuvre,M. Fraessdorf,W. Poewe.Eur J Neurol . 2012 (1)

[5]

Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial[J] . W. Poewe,O. Rascol,P. Barone,R.A. Hauser,Y. Mizuno,M. Haaksma,L. Salin,N. Juhel,A.H.V. Schapira.Neurology . 2011 (8)

[6]

Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease[J] . Robert A.Hauser,Anthony H.V.Schapira,OlivierRascol,PaoloBarone,YoshikuniMizuno,LaurenceSalin,MonikaHaaksma,NolwennJuhel,WernerPoewe.Mov. Disord. . 2010 (15)

[7]

Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies[J] . Clinical Therapeutics . 2009 (11)

[8]

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial[J] . Werner H Poewe,Olivier Rascol,Niall Quinn,Eduardo Tolosa,Wolfgang H Oertel,Emilia Martignoni,Markus Rupp,Babak Boroojerdi.Lancet Neurology . 2007 (6)

[9]

Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease[J] . P. Barone,L. Scarzella,R. Marconi,A. Antonini,L. Morgante,F. Bracco,M. Zappia,B. Musch.Journal of Neurology . 2006 (5)

[10]

Practice parameter: Initiation of treatment for Parkinson’s disease: An evidence-based review: Report of the Quality Standards Subcommittee of the American Academy of Neurology[J] . J. M. Miyasaki,W. Martin,O. Suchowersky,W. J. Weiner,A. E. Lang.Neurology: Journal of the American Heart Association . 2002 (1)

← 1 →